CBG cannabinoid effects
Pro Research Analysisby 
Searched over 200M research papers
Cannabigerol (CBG) Cannabinoid Effects: Pharmacology and Mechanisms
Cannabigerol (CBG) is a non-psychoactive cannabinoid found in Cannabis sativa. Unlike THC, it does not cause intoxication, making it an attractive candidate for therapeutic use. CBG is a precursor to both CBD and THC and is present in low concentrations in most cannabis plants, though it can be produced more efficiently through yeast biosynthesis or selective breeding Calapai2022Anokwuru2022Pérez2022.
CBG interacts with the endocannabinoid system, acting as a partial agonist at both CB1 and CB2 receptors, though it shows a stronger effect at CB2. It also modulates other targets, including transient receptor potential (TRP) channels, cyclooxygenase enzymes (COX-1 and COX-2), 5-HT1A serotonin receptors, and alpha-2 adrenergic receptors Calapai2022Navarro2018Anokwuru2022+1 MORE. These interactions allow CBG to influence a wide range of physiological processes.
CBG’s Anti-Inflammatory, Antioxidant, and Skin Health Effects
CBG has demonstrated significant anti-inflammatory and antioxidant properties in preclinical studies. It reduces the production of pro-inflammatory cytokines and reactive oxygen species, sometimes more effectively than CBD or vitamin C, especially in skin cells Calapai2022Anokwuru2022Pérez2022. In clinical studies, topical CBG improved skin barrier function and reduced redness after irritation, supporting its use in dermatological products .
CBG and Pain, Anxiety, and Cannabimimetic Actions
Despite its interaction with cannabinoid receptors, CBG does not produce the typical cannabimimetic effects (such as catalepsy, hypothermia, or antinociception) seen with THC. In animal studies, oral CBG did not reduce anxiety-like behavior or inflammatory pain, and only increased locomotor activity at very high doses . These findings suggest that CBG may not be effective for anxiety or pain relief when taken orally, at least in the tested models .
CBG’s Anticancer and Antitumor Potential
CBG has shown promising anticancer effects in various cell models. It can inhibit the growth of cancer cells, induce apoptosis (programmed cell death), and cause cell cycle arrest in leukemia, glioblastoma, and ovarian carcinoma cells Calapai2022Kadriya2024Lah2021+1 MORE. In glioblastoma, CBG was as effective as THC in reducing tumor cell viability and was particularly effective against therapy-resistant cancer stem cells. Combining CBG with CBD enhanced these effects, suggesting potential for combination therapies . In ovarian and leukemia cells, CBG’s cytotoxicity was dose- and time-dependent, and it sometimes worked synergistically with conventional chemotherapy drugs Kadriya2024Sooda2023.
Neuroprotective and Appetite-Stimulating Effects
CBG has demonstrated neuroprotective effects in preclinical studies, potentially benefiting neurodegenerative conditions Calapai2022Anokwuru2022Li2024. It also appears to stimulate appetite, which could be useful in conditions where appetite loss is a concern Calapai2022Anokwuru2022.
Safety, Side Effects, and Research Gaps
CBG is considered non-psychotropic and generally safe in preclinical studies, but there is a lack of robust clinical trials to confirm its efficacy and safety in humans for specific conditions Anokwuru2022Li2024. Some studies suggest that CBG can interfere with placental cell function and angiogenesis, raising concerns about its use during pregnancy .
Conclusion
CBG is a non-psychoactive cannabinoid with a broad pharmacological profile. It shows anti-inflammatory, antioxidant, neuroprotective, anticancer, and skin health-promoting effects, with promising results in preclinical models. However, its effectiveness for anxiety and pain relief is less clear, and more clinical research is needed to fully understand its therapeutic potential and safety, especially in humans.
Sources and full results
Most relevant research papers on this topic